# DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award

Source: https://welltoldgrants.com/grants/ht942524kcrpakciecsa-dod-kidney-cancer-academy-of-kidney-cancer-investigators/  
Official notice: https://www.grants.gov/search-results-detail/355337

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 2 awards worth $2.3 million in total. Applications closed on October 15, 2024.

| Field | Value |
|---|---|
| Opportunity number | HT942524KCRPAKCIECSA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | October 15, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 2 |
| Total funding | $2.3 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The Academy of Kidney Cancer Investigators (AKCI) is a virtual research capacity building and research mentoring platform that consists of Early-Career Scholar (ECS)/Designated Mentor pairs from different institutions and an Academy Leadership Team. The KCRP AKCIECSA is not a traditional career development award; the ECS is expected to conduct research, participate in monthly webinars, and annual workshops, and communicate and collaborate with other members of the Academy (other Early-Career Scholars, mentors, Academy Leadership Team) as well as with the kidney cancer advocacy community. The KCRP Academy of Kidney Cancer Investigators – Early-Career Scholar Award supports a unique, interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty emerging as potential leaders of kidney cancer research. The overarching goal of the AKCI is to advance kidney cancer research through development of highly productive kidney cancer researchers in a collaborative research and career development environment. The Academy Leadership Team, consisting of Academy Director and Deputy Director, serves as a resource for the ECS and mentors, assessing the progress of the ECS and facilitating communication and collaboration among all of the Early-Career Scholars and Designated Mentors, as well as with research and advocacy communities. In addition to fostering ECS scientific development, the AKCI, through its leadership by the Academy Leadership Team, provides professional and leadership development of the ECS to include skills and competencies needed to fund and manage a productive laboratory or research team. This FY24 program announcement is soliciting Early-Career Scholars and Designated Mentors to join the existing Academy of Kidney Cancer Investigators. This award mechanism enables the ECS (the Scholar named as the Principal Investigator [PI] on the application) to pursue a kidney cancer project that may be basic, translational, and/or clinical research. The Designated Mentor is not required to be at the same institution as the ECS.

## Questions people ask

### Is HT942524KCRPAKCIECSA still open?

No. It closed on October 15, 2024. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award?

Closed October 15, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $2.3 million in total across about 2 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.